HIV–1 infection and nervous system abnormalities among a cohort of intravenous drug users

W. Royal, M. Updike, O. A. Seines, T. V. Proctor, L. Nance-Sproson, L. Solomon, D. Vlahov, D. R. Cornblath, J. C. McArthur

Research output: Contribution to journalArticlepeer-review


A group of 109 HIV seropositive and 51 seronegative intravenous drug users was evaluated for the presence of HIV-1-related neurologic disease using clinical, neurologic, neuropsychological, and electrophysiologic evaluations. About 80% of HIV seropositive subjects had less than two constitutional symptoms. CD4 cell counts were less than 500/mm 3 among 56% of seropositive participants; three individuals were receiving zidovudine. Neurologic abnormalities were found frequently among the cohort, independently of HIV-1 serostatus; electrophysiologic abnormalities were uncommon. Participants from both serologic groups scored significantly lower on neuropsychological tests as compared with norms established for a cohort of homosexual men, and there was no clear association between HIV-1 serostatus and performance on these tests. This study suggests that HIV infection was not the dominant cause of neurologic abnormalities among the study cohort.

Original languageEnglish (US)
Pages (from-to)1905-1910
Number of pages6
Issue number12
StatePublished - Dec 1991

ASJC Scopus subject areas

  • Clinical Neurology


Dive into the research topics of 'HIV–1 infection and nervous system abnormalities among a cohort of intravenous drug users'. Together they form a unique fingerprint.

Cite this